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AbsTrACT
background The human enthesis conventional T cells 
are poorly characterised.
Objectives To study the biology of the conventional T 
cells in human enthesis.
Methods cD4+ and cD8+ T cells were investigated 
in 25 enthesis samples using immunofluorescence, 
cytometrically, bulk rnaseq and quantitative real- time 
Pcr following anti- cD3/cD28 bead stimulation to 
determine interleukin (il)- 17a and tumour necrosis 
factor (TnF) levels. T- cell receptor (Tcr) repertoires were 
characterised and a search for putative T- cell reactivity 
was carried out using Tcr3 database. The impact of 
pharmacological antagonism with retinoic acid receptor- 
related orphan nuclear receptor gamma t inhibitor 
(rorγti), methotrexate and phosphodiesterase type 4 
inhibitor (PDe4i) was investigated.
results immunofluorescence and cytometry suggested 
entheseal resident cD4+ and cD8+ T cells with a 
resident memory phenotype (cD69+/cD45ra-) and 
tissue residency gene transcripts (higher nr4a1/ahr and 
lower KlF2/T- bet transcripts). Both cD4+ and cD8+ T 
cells showed increased expression of immunomodulatory 
genes including il-10 and TGF-β compared with 
peripheral blood T cells with entheseal cD8+ T cells 
having higher cD103, cD49a and lower siPr1 transcript 
that matched cD4+ T cells. Following stimulation, cD4+ 
T cells produced more TnF than cD8+ T cells and il- 17a 
was produced exclusively by cD4+ T cells. rnaseq 
suggested both cytomegalovirus and influenza a virus 
entheseal resident T- cell clonotype reactivity. TnF and 
il- 17a production from cD4+ T cells was effectively 
inhibited by PDe4i, while rorγti only reduced il- 17a 
secretion.
Conclusions Healthy human entheseal cD4+ 
and cD8+ T cells exhibit regulatory characteristics and 
are predicted to exhibit antiviral reactivity with cD8+ 
T cells expressing higher levels of transcripts suggestive 
of tissue residency. inducible il- 17a and TnF production 
can be robustly inhibited in vitro.
InTrOduCTIOn
The enthesis is the connective tissue junction where 
ligaments and tendons attach to the bone and is a 
key target tissue for inflammation in spondyloar-
thritis (SpA), including psoriatic arthritis (PsA) and 
ankylosing spondylitis (AS) where inflammation is 
evident in both the enthesis soft tissue and the adja-
cent anchoring perientheseal bone (PEB).1 These 
sites are exposed to mechanical stress and are char-
acterised by microdamage that is accompanied by 
tissue repair responses that in most cases leads to 
normal healing.2–5 However, in genetically prone 
subjects, those with dysbiosis and other factors, the 
post- inflammation repair processes may be exces-
sive and eventually lead to new bone formation.3 6 7
Animal model studies suggest the primacy of 
enthesis organ disease in experimental SpA which 
was originally shown in the DBA-1 mouse model 
Key messages
What is already known about this subject?
 ► Recent studies have shown that normal 
human spinal entheses harbour several innate 
immune cell populations including type 3 innate 
lymphoid cells, myeloid cells and also γδ T cells. 
However, a description of adaptive immune T 
cells at the enthesis has not been reported.
What does this study add?
 ► This study has shown the presence of entheseal 
resident conventional T cells with inducible 
production of interleukin-17 and tumour 
necrosis factor. The entheseal CD8+ T cells 
in particular had features of tissue resident 
memory cells and predicted reactivity to 
common viral antigens.
How might this impact on clinical practice or 
future developments?
 ► The presence of conventional CD4+ and CD8+ 
T cells in the normal enthesis provides the first 
direct immunological evidence for adaptive 
immunity at the enthesis. This provides a basis 
for studies to explore T cells in the pathology 
of axial inflammation in spondyloarthropathy- 
related disorders.
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and also in tumour necrosis factor (TNF) transgenic models and 
subsequently in other models.8 9 Given the fibrocartilageneous 
and ligamentous/fibrous nature of the enthesis, the actual inser-
tion region was not thought to contain cells of the immune system. 
However, several pioneering studies showed the presence of a 
novel T- cell population in murine interleukin (IL)-23/IL-17 axis- 
dependent disease.8 In mouse models, activated Vγ6+CD27− γδ 
T cells were found in uninflamed normal entheseal tissue and 
constituted the largest resident T- cell subset.10 11 Galvanised by 
these novel animal model experiments, we reported that normal 
human spinal entheses harbour several innate immune cell popu-
lations including type 3 innate lymphoid cells (ILCs), myeloid 
cells and also γδ T cells that express IL- 23R, with inducible 
IL- 17A and IL- 17F transcript expression.12 13
A remarkable feature of human SpA- related disorders are 
the multiple genetic associations suggesting a role for adaptive 
immunity, especially conventional T cells, in disease immuno-
pathogenesis—ranging from MHC class- I associations in AS 
and PsA to ERAP-1 and RUNX3 SNPs (single nucleotide poly-
morphisms) among others.14 15 The most prominent MHC 
class- I association, HLA- B27, is present in ~90% of AS patients 
pointing to CD8+ T cells in pathogenesis.16 Conventional T 
cells are known to be present in the enthesis along with PEB 
infiltrating lymphocytes in patients with SpA.17 Indeed, the 
anchoring PEB is the major site of inflammation or osteitis in AS. 
The identification of tissue- resident memory T cells (TRM) that 
occupy non- lymphoid organs such as skin, lung and the gastroin-
testinal tract raises the possibility that such cells are also resident 
within normal enthesis.18 TRM cells are highly heterogeneous 
with respect to anatomical positioning, phenotype, molecular 
regulation and effector function.19
A cardinal feature of the enthesitis- associated pathology of 
SpA is the response to TNF and IL- 17A inhibition,20 21 but the 
biological basis for this remains undefined given the rudimentary 
knowledge about human enthesis immunity. However, a recent 
clinical trial of IL-23 blockade reported disappointing results 
in AS patients,22 suggesting a mechanism for IL-17 production 
independent of IL-23 at the enthesis.23 These translational ther-
apeutic insights suggest that TRM cells might be key IL- 17A 
and TNF producers. In the current study, we aimed to charac-
terise human entheseal CD4+ and CD8+ T cells and assessed 
their ability to express SpA- related cytokines including TNF and 
IL- 17A following CD3/CD28 stimulation. We also evaluated the 
impact of SpA relevant therapeutic agents (methotrexate (MTX) 
and inhibitors (i) of PDE4 and RORγt) on attenuating TNF and 
IL- 17A production towards efforts to develop an in vitro model 
system for predicting potential drug efficacy for enthesitis.
MATerIAls And MeTHOds
Patients and samples
The study protocol was approved by the North West- Greater 
Manchester West Research Ethics Committee. Human inter-
spinous process and matched peripheral blood were obtained 
from 25 patients (with informed written consent) (mean age of 
42.4±27, median age of 39, and female to male ratio of 3:2) 
who underwent elective spinal surgery for either decompres-
sion or scoliosis correction using methods previously reported.12 
Further details regarding the complete patient cohort are 
reported in online supplementary table 3.
Isolation of primary cells from enthesis and matched blood
Entheseal samples were separated into entheseal soft tissue (EST) 
and PEB and both were enzymatically digested as previously 
described (online supplementary figure 1).12 For both cell prepa-
rations, blood and entheseal cells, density gradient separation 
(Lymphoprep) was conducted in order to obtain peripheral 
blood mononuclear cells (PBMCs) and entheseal mononuclear 
cells (EMCs), respectively, using methods previously described.24
Immunophenotyping of entheseal and peripheral blood 
derived T cells
EMCs or PBMCs were stained with zombie aqua (live/dead 
discrimination), anti- CD45 (to exclude non- leucocytes), CD3 
(T- cell inclusion), CD4 and CD8. Tissue resident memory 
cells were identified by CD69+ and naive/circulating cells by 
CD45RA+. All flow cytometry was conducted on the Cytoflex 
LX (Beckman Coulter) and subsequent analysis completed using 
the CytExpert Acquisition and Analysis Software (V.2.3) and 
FlowJo software (Tree Star, USA). A full list of antibodies, clones 
and fluorophores can be found in online supplementary table 1.
Histology and immunofluorescence microscopy
For immunofluorescence microscopy, frozen sections of EST 
were incubated with an Alexa Fluor 647 labelled antibody 
against CD3 (clone UCHT1, BD Biosciences) and counterstained 
with 4′,6- diamidine-2′-phenylindole dihydrochloride.
Magnetic cell separation
Following isolation of EMCs from digested entheseal samples 
and PBMCs from processed blood, CD4+ and CD8+ T cells 
were isolated using biotinylated anti- CD4 or CD8 (both from 
Miltenyi Biotech). Cells were isolated using magnetic separation 
(Miltenyi Biotech LS columns), according to the manufacturer’s 
instructions.
Cell culture
Following cell isolation, CD4+ and CD8+ T cells were plated 
out in a 96- well plate (minimum of 5×104 cells/well) in RPMI 
(GIBCO) containing 10% fetal calf serum and 1% penicillin/
streptomycin. For inhibition studies, cells were incubated 
with the following compounds for 1 hour in standard culture 
conditions (5%CO2, 37°C): RORγt inhibitor 10 µM
25 (Pfizer), 
MTX, 5 mg/mL (Cayman Chemical), rolipram (a PDE4 inhib-
itor) 10 µM (Cayman Chemical) or dimethyl sulfoxide (DMSO) 
control (0.1%). All drugs were diluted to maintain a final concen-
tration of 0.1% DMSO. Cells were stimulated using anti- CD3/
CD28 (GIBCO) for 48 hours. To test the potential of compounds 
to affect cell viability, flow cytometry was used to assess CD45+, 
CD3+, CD4/CD8+ and live dead viability by aqua zombie.
TnF and Il-17A determination by elIsA in entheseal 
stimulated cell supernatants
Following 48 hours of stimulation, cells were removed by 
centrifugation and supernatant was stored at −80°C. Concentra-
tions of TNF and IL- 17A were measured using sandwich ELISAs 
from eBioscience/Thermo Fisher (Waltham, Massachusetts, 
USA). ELISAs were carried out according to the manufacturer’s 
protocol. Following this, pg/mL and pg/cell were calculated.
Intracellular flow cytometry for protein measurement
Enthesis mononuclear cells, 5×106, were plated out and stim-
ulated with anti- CD3/CD28 as before in the presence of Golgi 
plug (BD) for 3 hours. The cells were fixed using Intraprep kit 
(Beckman Coulter) and stained intracellularly with IL- 17A and 
TNF.
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Quantitative real-time PCr for transcript analysis
T cells were sorted using an Influx (BD) cell sorter directly 
into RNA extraction buffer, supplied as a component of the 
PicoPure RNA isolation kit (Thermo Fisher). cDNA was 
synthesised with a reverse transcription kit (Fluidigm) then 
underwent preamplification (18 cycles) using a pre- amp 
master mix (Fluidigm) with a solution containing all primer 
sets. All primers were purchased from Applied Biosys-
tems. Transcript analysis was performed by qPCR using 
the Biomark HD gene expression system (Fluidigm); values 
displayed are log 10ΔCt relative to the HPRT1 housekeeping 
gene.
qRT- PCR was completed using the TaqMan Gene expres-
sion assay as per the manufacturer’s instructions (Applied 
Biosystems). Samples, no template control (NTC) and positive 
controls (pooled cDNA) were loaded onto either a MicroAmp 
Optical 96- Well Reaction Plate (Applied Biosystems) or a 
MicroAmp Optical 384- Well Reaction Plate (Applied Biosys-
tems) and run on either the Quantstudio 5 or Quantstudio 7 
instrument, respectively (both from Applied Biosystems) using 
the Quantstudio Design and Analysis software (V. 1.4, Thermo 
Scientific), the Comparative Threshold (Ct) value was subse-
quently normalised using the HPRT1 housekeeping gene and 
unstimulated control for 2-ΔΔCt. All primers were purchased 
from Applied Biosystems. A full list of primers used can be 
found in online supplementary table 2.
rnAseq
Bulk RNAseq was performed on CD3+CD45+CD4+ or CD8+ 
T- cell subsets isolated from entheseal digests n=4 for both 
PEB and EST. RNA was then purified using the PicoPure RNA 
isolation kit (Thermo Fisher), RIN (RNA Integrity Number) 
scores and concentration in ng/μL were determined by Tape 
Station prior to RNAseq analysis. Following this, MiXCR 
(V.3) was used to extract clonal TCR rearrangements. CDR3 
(complementary determining region 3) amino acid sequences 
were used to interrogate the TCR3 database (https:// tcr3d. 
ibbr. umd. edu/) in order to assess epitope specificities based 
on model- based scoring matrices (PAM-30). Further details of 
bulk RNAseq analysis using the Galaxy platform are displayed 
in online supplementary methods 1.
statistical analysis
Analysis was performed using GraphPad Prism software 
(GraphPad Software, La Jolla, California, USA) and statistical 
analysis was performed in SPSS (IBM SPSS Statistics V.25, 
USA). Error bars represent the SE of the mean (SEM); refer 
to the Results section for specific tests used per experimental 
procedure.
resulTs
Conventional Cd4+ and Cd8+ T cells are present in the 
human enthesis
To investigate entheseal T- cell topography, anti- CD3 immu-
nofluorescence staining was used (tonsil tissue used as a 
positive control) (figure 1A–C). EST T cells were sparse and 
typically located in small clusters (figure 1C). Following enzy-
matic digestion of the samples, flow cytometry was used iden-
tify CD4+ and CD8+ T cells from the enthesis (figure 1D). 
Clear populations of CD4+ and CD8+ T cells were readily 
identifiable.
Transcriptional and flow cytometric profiling of entheseal 
Cd4+ and Cd8+ T cells compared with peripheral blood 
supports TrM status
Comparison of blood- derived and entheseal- derived (from 
both PEB and EST) CD4+ and CD8+ T cell transcripts 
suggests that entheseal T cells are tissue resident with higher 
AhR and NR4A1 transcript expression. Contrastingly, tran-
scripts indicative of circulating T cells, such as KLF2 and T- bet, 
show higher transcript expression in blood T cells (figure 2A). 
Entheseal CD4+ and CD8+ T cells also show higher expres-
sion of growth factors and molecules associated with tissue 
repair and homeostasis, such as vascular endothelial growth 
factor A (VEGF- A), transforming growth factor beta 1 (TGF-
β1) and IL-10 when compared with matched peripheral blood 
(figure 2A).
Flow cytometry was used to further phenotype both 
blood and entheseal T cells. Entheseal- derived CD4+ 
and CD8+ T cells showed significantly higher CD69 expres-
sion, supporting a tissue resident memory (TRM) phenotype 
(figure 2B). In contrast, a greater percentage of peripheral 
blood T cells showed CD45RA expression compared with 
entheseal- derived T cells, further supporting tissue residency 
for entheseal T cells (figure 2B).
Induction of Il-17A and TnF in entheseal Cd4+ and Cd8+ T 
cells
Following anti- CD3/CD28 stimulation, a significantly greater 
proportion of entheseal- derived CD4+ T cells increased 
IL- 17A and TNF production when compared with unstimu-
lated. There was a significant increase in the proportion of 
CD8+ enthesis T cells upregulating TNF production, and 
although IL-17 production trended upwards following stimu-
lation, this was not statistically significant (figure 3).
Assessment of entheseal bone and soft tissue Cd4+ and 
Cd8+ T-cell repertoire
Following RNASeq, the initial analysis of conventional αβ 
TCRs highlighted the marked reduction in clonal diversity in 
EST compared with PEB conventional T cells, where there was 
evidence to suggest that PEB subpopulations are more diverse 
than their EST counterparts. However, more sorted cells were 
generally present in PEB compared with EST, where CD4+ 
populations contained (17 353±6147 cells and 1419±988 
cells, respectively) (figure 4A), the same trend is also seen in 
CD8+ populations (20 524±5545 cells and 1384±1076 cells, 
respectively) (figure 4B). We assessed T- cell clones for poten-
tial viral reactivity, by looking at epitope specificities from the 
TCR3 database (https:// tcr3d. ibbr. umd. edu/); out of the 13 
potentially reactive clonal sequences, the most common viral 
targets were Cytomegalovirus (CMV) in eight sequences and 
influenza A virus (IAV) in two sequences.
Bulk RNAseq analysis of the CD4+ and CD8+ T cells (n=6 
in total) was undertaken for tissue residency markers including 
CD69, CD103, CD49a and S1PR1 following normalisation 
with the GADPH housekeeping gene. As confirmed by flow 
cytometry CD69 transcript was substantially higher in enthesis 
compared with blood but the other transcripts were compa-
rable between enthesis and blood. However, in four enthe-
seal samples, CD103 and CD49a transcripts were 3.8- fold 
and 4.6- fold higher in entheseal CD8+ T cells, respectively, 
compared with CD4+ entheseal T cells with S1PR1 transcripts 
being correspondingly reduced. From other studies, it appears 
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Figure 1 Immunofluorescence and cytometry for entheseal CD4+ and CD8+ T cells. Anti- CD3 immunofluorescence staining showing T cells in 
tonsil as positive control (A), in enthesis at lower power (B) and at higher power (C) where a small region of CD3 positivity in (B) is magnified. (D) 
Phenotypic identification of CD4+ and CD8+ T cells by fluorescence- activated cell sorting (FACS) following digestion of human enthesis. Following 
doublet exclusions, cells were gated on CD45+ (all white cell count) and CD3+ (all T cells); this gate was then further subdivided into CD4+ and CD8+ 
T cells.
that expression of CD69 leads to the inactivation and inter-
nalisation of S1PR1 which supports our concept of these cells 
showing tissue residency.26
Analysis of regulatory markers in entheseal and blood-
derived T cells
Given the high basal TGFβ transcript expression and the 
absence of proinflammatory cytokine transcripts (figure 2A), we 
further investigated whether entheseal T cells were regulatory 
in nature. While a population of Tregs (CD4+CD25+FoxP3+) 
was readily identifiable in the blood, this was not the case in the 
enthesis (figure 5A). To further induce a regulatory phenotype, 
we used a series of clinically relevant compounds to assess their 
effects on T- cell regulatory phenotype markers (FoxP3 and 
TGFβ1). Isolated T cells were stimulated with anti- CD3/CD28 
with and without RORγt inhibitor, MTX and PDE4 inhibitors 
(figure 5B–D). Only the phosphodiesterase type 4 inhibitor 
(PDE4i) significantly upregulated FoxP3 expression in enthe-
seal CD4+ T cells (figure 5B). With regard to the expression of 
TGFβ, the therapeutic agents resulted in no significant changes 
in expression, except for entheseal CD4+ T cells, where PDE4i- 
treated cells showed higher expression (figure 5C). MTX signifi-
cantly reduced the expression of FoxP3 from entheseal CD8+ 
T cells (figure 5D).
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Figure 2 Transcriptional and flow cytometric profiling of entheseal T cells. CD4+ and CD8+ T cells were sorted from EST, PEB and peripheral blood 
(PB). Basal expression of cytokines, chemokines, growth factors, signalling molecules, tissue residency markers was assessed (A). Colour coding refers 
to differentially expressed genes where values less than −1 indicate low expression and values greater than 1 indicate higher expression, those with 
grey boxes indicate no values, values displayed are log 10ΔCt relative to HPRT (n=16 samples). Flow cytometry (B) was used to assess the % of 
circulating memory T cells (CD69- CD45RA+) and resident memory T cells (CD69 +CD45RA-) in both CD4 +and CD8+ T cells in PEB, EST and PB paired 
t tests, n=4. *p<0.05; **p<0.01; ***p<0.001. EST, entheseal soft tissue; PEB, perientheseal bone.
rOrγti, MTX and Pde4i impact on enthesis Cd4 and Cd8 T-cell 
cytokine production
We next evaluated the effect of disease relevant drugs on enthe-
seal and blood- derived T cells including those not thought to be 
generally efficacious for enthesitis such as MTX and those that 
may show efficacy including phosphodiesterase type 4 inhib-
itor (PDE4i) and retinoic acid receptor- related orphan nuclear 
receptor gamma t inhibitor (RORγti). The latter was evaluated 
as RORγt is a key transcription factor driving Th17 cell differ-
entiation, and production of IL- 17A, IL- 17F and IL-22 in innate 
and adaptive immune cells.27 Compounds were tested for their 
ability to attenuate TNF and IL- 17A secretion. CD4+ and CD8+ 
T cells were isolated from the enthesis and matched blood, and 
stimulated with anti- CD3/CD28, and TNF and IL- 17A were 
measured by ELISA. CD4+ T cells robustly secreted IL- 17A and 
TNF, whereas CD8+ only secreted TNF (IL- 17A was undetect-
able, data not shown). Both PDE4i and RORγti significantly 
reduced IL- 17A secretion from both blood and enthesis- derived 
CD4+ cells (figure 5F), whereas MTX failed to significantly 
attenuate IL- 17A secretion in CD4+ entheseal- derived cells; 
however, MTX did attenuate IL- 17A secretion in blood. TNF 
derived from both entheseal and blood- derived CD4+ T cells 
was significantly attenuated by PDE4i, but not RORγti or MTX 
(figure 5F). Similarly, CD8+ T- cell- derived TNF was attenuated 
by PDE4i, but not RORγti or MTX (figure 5G).
Cell viability was tested for all three compounds with none of 
the compounds significantly altering either entheseal CD4+ or 
CD8+ T cells (figure 5H). Next, we assessed any potential differ-
ence of drug inhibition between the entheseal and blood- derived 
T cells (figure 5I). CD4+ IL- 17A inhibition by RORγti showed 
no significant difference between enthesis and blood. For both 
T- cell subsets, there was no significant differences between inhi-
bition of TNF or IL- 17A by PDE4i between the enthesis and 
blood (figure 5I). The findings from peripheral blood- derived T 
cells with drug inhibition were generally similar to the enthesis.
dIsCussIOn
We report, for the first time, the presence of conventional 
CD4+ and CD8+ T cells in the human enthesis including PEB 
and spinal soft tissue. In health, these exhibited regulatory 
features including high TGFβ1 transcripts, but low proin-
flammatory cytokine transcript levels and protein production. 
Unlike for matched blood, there was no clear FoxP3 regulatory 
T- cell population identifiable at the healthy enthesis, although 
T- cell stimulation in the presence of PDE4 inhibition was 
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Figure 3 Intracellular interleukin (IL)- 17A and tumour necrosis factor (TNF) induction in entheseal CD4+ and CD8+ T cells. Following digestion of 
human entheseal samples (PEB), cells were stimulated with anti- CD3/CD28 in the presence of Golgi plug for 3 hours. CD4+ and CD8+ T cells were 
subsequently stained intracellularly for TNF and IL- 17A. TNF or IL- 17A was quantified (A) following assessment by flow cytometry (B). n=3. Paired t 
tests. *p<0.05; **p<0.01; ***p<=0.001.
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Figure 4 Assessment of the conventional T- cell repertoire in peri- entheseal bone (PEB) and entheseal soft tissue (EST) within the CD4+ and CD8+ 
T- cell subpopulations. Following MiXCR outputs, RNAseq data were used to determine potential clonality within the T- cell subpopulations, from both 
PEB and EST in both CD4+ (A) and CD8+ (B) T- cell populations where each individual clone is represented by a different colour. n=4 (2 female, 2 
male); mean age=30.2 years. Where P1 relates to the first patient, P2 relates to the second patient, P3 relates to the third patient and P4 relates to 
the fourth patient.
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Figure 5 The effect of compounds of regulatory and inflammatory protein and gene expression basal levels of FOXP3 were measured by flow 
cytometry in unstimulated perientheseal bone (PEB) and peripheral blood mononuclear cell (PBMC) and show a clear population of Tregs in blood but 
not the enthesis (A). CD4+ and CD8T cells were isolated from PEB or matched peripheral blood and stimulated with anti- CD3/CD28 for 48 hours with 
and without therapeutic agents indicated. qRT- PCR was used to determine the expression of FOXP3 and TGFβ1. (B–E) 2-ΔΔCt was used to measure 
relative expression fold change. IL- 17A and TNF protein secretion was measured by ELISA (F–G) (n=8). The effect of therapeutic agents on CD4+ 
and CD8+ viability following a 48- hour incubation (H), n=3. The difference in efficacy between phosphodiesterase type 4 inhibitor (PDE4i) and retinoic 
acid receptor- related orphan nuclear receptor gamma t inhibitor (RORγti) in attenuating cytokine secretion in enthesis (PEB) compared with blood in 
CD4+ populations and CD8+ populations (I). One- way t test, *p<0.05; **p<0.01.
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capable of FoxP3 transcript upregulation. We also confirmed 
that these entheseal T cells have the capability to secrete 
pivotal disease- relevant cytokines such as TNF and IL- 17A 
following CD3/CD28 stimulation, without the use of other 
exogenous cytokines such as IL-23. Enthesis- derived CD4+ 
T cells secreted both TNF and IL- 17A following stimulation, 
whereas enthesis- derived CD8+ T cells only produced clearly 
detectable TNF.
Through mouse models and clinical observations, both TNF 
and IL- 17A have been heavily implicated in enthesitis- related 
pathology.10 28 While innate lymphocytes are major inflamma-
tory cytokine producers in mice,11 our findings confirm that 
conventional T- cell populations that can express these cyto-
kines are present at the normal enthesis. Given the MHC- I 
and MHC- II associations with human SpA spectrum disorders, 
our findings highlight the importance of the investigation of 
entheseal T cells in pathological conditions such as AS and 
PsA.
Central to the T- cell antigen response is the CDR3 (Comple-
mentary determining region 3) which provides both antigen 
specificity and affinity. The bulk RNAseq data looking for 
CDR3 showed a more diverse repertoire in PEB than EST, 
arguably this could be due to the haematopoietic marrow 
that PEB contains. The ability to demonstrate clonal TCR 
usage provides a useful tool to dissect the immunopathology 
of inflammatory diseases, when looking at the epitope spec-
ificities from the TCR3 database (https:// tcr3d. ibbr. umd. 
edu/), and out of the 13 sequences with potential targets, 
the most common finding was CMV in eight sequences and 
IAV in two sequences, respectively. Bulk RNAseq highlights 
the presence of clonal populations in both CD4+ and CD8+ 
conventional T- cell populations with the latter scoring higher 
on model- based scoring matrices (PAM-30). Overall, these 
results showing high diversity and limited clonality in PEB and 
vice versa in the EST suggest that the conventional T cells in 
each of these compartments are distinct. EST T cells show a 
limited repertoire, while PEB T cells maintain their capacity 
to respond to a range of diverse antigens. This likely reflects 
the greater immune cell numbers that accumulate at the PEB, 
which in addition to being the target site for inflammation in 
AS also contains normal bone marrow.
The extremely low levels of IL- 17A production from enthe-
seal CD8+ T cells in comparison to CD4+ T cells from both 
blood and enthesis following stimulation reinforces the view 
that CD4+ T cells are more important for cytokine produc-
tion than CD8+ T cells.29 CD8+ IL-17 producing (Tc17) cells 
have been identified in PsA synovial fluid, where they exhibit 
a tissue resident memory (TRM) phenotype, with most present 
in the effector tissues and a small number continuing to recir-
culate in the secondary lymphoid organs ready for antigen 
re- encounter.30 Tc17 cells are highly plastic in nature and can 
switch to interferon-γ producing Tc1 cells in certain tissues.31
Entheseal CD4+ and CD8+ T cells are transcriptionally, 
phenotypically and functionally distinct from matched recir-
culating peripheral T cells. Entheseal T cells also have higher 
expression of transcripts involved in repair and tissue homeo-
stasis, such as IL-10, TGFβ1 and VEGF- A when compared 
with their blood counterparts. In the large majority of cases, 
these repair processes consist of self- limited inflammation and 
may lead to the complete healing of the damaged tissue.32 
However, in some cases, in those subjects with genetic predis-
position, enthesitis may exhibit chronicity as is the case in 
SpA- associated disorders where it is considered a pathogno-
monic feature.33
The ability of disease relevant compounds to attenuate 
IL- 17A and TNF production was also evaluated. It is well 
known that RORγt is a transcription factor and regarded as 
the master regulator of IL- 17A.34 RORγt antagonists have 
been investigated in numerous murine models of inflammation 
and autoimmunity, yielding promising results.35 36 In human 
studies, RORγt inhibition was recently shown to inhibit 
IL- 17A from synovial T cells from both PsA and AS patients 
and also blood T cells.37 38 We also showed that rolipram, a 
PDE4 inhibitor, was able attenuate TNF and IL- 17A secretion 
CD4+ T cells and TNF from CD8+ T cells. Our system may 
provide a model for testing the impact of drugs on the adap-
tive immune system in preclinical work in SpA but clear differ-
ence between activated peripheral blood cells undergoing drug 
antagonism were not evident.
The T memory subsets are crucial for maintaining immu-
nological memory and include TCM (T central memory 
CCR7+ and CD45RA-), TEM (T effector memory, 
CCR7- and CD45RA), TRM (tissue resident memory cells, 
CD69+CD45RA- and CD103+ in CD8+ subpopulations) and 
TSCM a subset of TCM cells (T memory stem cells, CCR7+C-
D62L+CD45RA+) which show enhanced self- renewal capa-
bilities.39 Our results supported, but do not prove, a TRM 
phenotype in PEB and EST in contrast to the circulating 
memory (CD45RA+CD69-) peripheral blood phenotype. This 
was especially the case for CD8+ T cells that expressed higher 
CD103 and CD49a transcript compared with matched CD4+ 
T cells which emerged from our additional bulk RNAseq anal-
ysis. However, recent studies have demonstrated the presence 
of TRM T cells in different tissues including synovial fluid 
and gut in SpA patients,40 41 and therefore whether these cells 
recirculate between these different sites awaits elucidation. 
The downregulation of KLF2, an important transcription 
factor for S1PR1 expression, highlights the potential of enthe-
seal cells in maintaining their tissue retention capabilities and 
TRM phenotype. Interestingly, the transcription factor Hobit 
(Homolog of Blimp-1 in T cells, also known as ZNF683), 
which directs a tissue- resident programme and prevents 
egress of immune cells,42 was downregulated in both CD4+ 
and CD8+ entheseal T cells, respectively, compared with 
peripheral blood. This result contradicts previous findings in 
mice where Hobit is known to be upregulated, highlighting a 
difference between human and mouse models and the signa-
ture TRM- associated genes.43 Unlike other target tissues in 
SpA such as the gut and skin, where direct interfacing with 
potential microbial pathogens occurs, the basis for such popu-
lations in the normal enthesis in health is poorly understood 
and may be related to tissue repair and integrity.
In conclusion, this work shows that the normal human 
enthesis harbours conventional T cells with inducible produc-
tion of IL-17 and TNF. The CD8+ T cells at the enthesis 
displayed markers suggestive of tissue residency, but further 
single cell RNAseq work is planned to better define this. 
The results also support the idea that IL-17 production may 
be independent of IL-23, where the in vitro enthesitis model 
allows for TCR engagement via CD3/CD28 crosslinking. 
These findings provide a base for future studies to define the 
role of adaptive immune cells in the pathogenesis of enthesitis 
in active early SpA. Further studies are needed to extend these 
findings into diseased tissue in SpA.
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